Abstract:Aldose Reductase (AR) reduces a variety of substrates, such as aldehydes, aldoses and corticosteroids. It is the first and rate-limiting enzyme of the polyol pathway and is an important target enzyme for diabetes-associated complications, including retinopathy, neuropathy, and nephropathy. Inhibitors targeting this enzyme are structurally different and some of them have side effects. In existing publications, computational techniques are applied to investigate the binding affinities of existing inhibitors and predicting the affinities of newly designed ligands. However, these calculations only employ coarse and approximated methods such as docking and MM/PBSA. Brute force simulations are employed to study the dynamics of the system but no converged statistics is obtained. As a result, these computations provide results not consistent with experimental values and large discrepancies exist. In the current work, we employ the enhanced sampling technique of alchemical free energy simulation to calculate the binding affinities of several ligands targeting AR. The statistical error is defined with care and the correlation in the time-series data is fully considered. The statistically optimal estimators are used to extract the free energy estimates and the predicted results are in agreement with the experimental values. Less computationally demanding end-point free energy methods are also performed to compare their efficiency with the alchemical methods. As is expected, the end-point methods are of less accuracy and reliability compared with the alchemical free energy methods. The decomposition of the free energy difference in each alchemical transformation into the enthalpic and entropic components gives further insights on the thermodynamics. The enthalpy-entropy compensation is observed in this case. As the structural data obtained from experiments are only snapshots and more details are needed to understand the dynamics of the protein-ligand system, the conformational ensemble is analyzed. We identify important residues involved in the protein-ligand binding case and short-lived interactions formed due to fluctuations in the conformational ensemble. The current work shed light on the atomic detailed understanding of the dynamics of AR-inhibitors interactions.

ER/AR Multi-Conformational Docking Server: A Tool for Discovering and Studying Estrogen and Androgen Receptor Modulators

3d-Qsar And Docking Studies Of Estrogen Compounds Based On Estrogen Receptor Beta

Molecular Docking, Molecular Dynamics Simulation, and Structure-Based 3D-QSAR Studies on the Aryl Hydrocarbon Receptor Agonistic Activity of Hydroxylated Polychlorinated Biphenyls.

Combining Docking and Comparative Molecular Similarity Indices Analysis (comsia) to Predict Estrogen Activity and Probe Molecular Mechanisms of Estrogen Activity for Estrogen Compounds

D3CARP: a comprehensive platform with multiple-conformation based docking, ligand similarity search and deep learning approaches for target prediction and virtual screening

LARMD: Integration of Bioinformatic Resources to Profile Ligand-Driven Protein Dynamics with a Case on the Activation of Estrogen Receptor.

Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts.

Computational Studies of Interactions Between Endocrine Disrupting Chemicals and Androgen Receptor of Different Vertebrate Species

Correction to Structures of Endocrine-Disrupting Chemicals Determine Binding to and Activation of the Estrogen Receptor Α and Androgen Receptor

Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy

DRAR-CPI: a Server for Identifying Drug Repositioning Potential and Adverse Drug Reactions Via the Chemical-Protein Interactome.

fastDRH: a webserver to predict and analyze protein-ligand complexes based on molecular docking and MM/PB(GB)SA computation

Estrogen Receptor Alpha Binders for Hormone-Dependent Forms of Breast Cancer: e-QSAR and Molecular Docking Supported by X-ray Resolved Structures

Prediction of binding affinity for estrogen receptor α modulators using statistical learning approaches

Understanding Aldose Reductase-Inhibitors interactions with free energy simulation

CB-Dock: a web server for cavity detection-guided protein-ligand blind docking

Development of a comprehensive open access "molecules with androgenic activity resource (MAAR)" to facilitate risk assessment of chemicals

Interpretable machine learning for the identification of estrogen receptor agonists, antagonists, and binders

Quantitative Structure-Activity Relationship of Compounds Binding to Estrogen Receptor Β Based on Heuristic Method

Computational Analysis of Residue-Specific Binding Free Energies of Androgen Receptor to Ligands

Docking and CoMSIA Studies on Steroids and Non-Steroidal Chemicals As Androgen Receptor Ligands.